[Federal Register Volume 60, Number 23 (Friday, February 3, 1995)]
[Notices]
[Page 6748]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 95-2652]
-----------------------------------------------------------------------
SECURITIES AND EXCHANGE COMMISSION
Issuer Delisting; Notice of Application to Withdraw From Listing
and Registration; (NuMed Home Health Care, Inc., Common Stock, $.001
Par Value) File No. 1-12992
January 30, 1995.
NuMed Home Health Care, Inc. (``Company'') has filed an application
with the Securities and Exchange Commission (``Commission''), pursuant
to Section 12(d) of the Securities Exchange Act of 1934 (``Act'') and
Rule 12d2-2(d) promulgated thereunder, to withdraw the above specified
security (``Security'') from listing and registration on the American
Stock Exchange, Inc. (``Amex'').
The reasons alleged in the application for withdrawing the Security
from listing and registration include the following:
According to the Company, its Board of Directors (``Board'')
unanimously approved a resolution on January 10, 1995, to withdraw the
Security from listing on the Emerging Company Marketplace of the Amex
(``Amex/ECM'') and, instead, list the Security on the National
Association of Securities Dealers Automated Quotation Small Cap Market
System/National Market System (``NASDAQ/NMS''). The Company believes
that:
(1) The NASDAQ SmallCap Market system of competing market-makers
will result in increased visibility and sponsorship for the Security
than is presently the case with the single specialist assigned to the
Security on the Amex/ECM;
(2) The NASDAQ SmallCap Market system will offer the Company's
shareholders more liquidity than presently available on the Amex/ECM
and less volatility in quoted price per share when trading volume is
slight;
(3) The NASDAQ SmallCap Market system will offer the opportunity
for the Company to more effectively consummate its proposed offering of
1,100,000 Units; and
(4) Firms making a market in the Company's Security on the NASDAQ
SmallCap Market system will be inclined to issue research reports
concerning the Company, thereby increasing the number of firms
providing institutional research and advisory reports.
Any interested person may, on or before February 21, 1995, submit
by letter to the Secretary of the Securities and Exchange Commission,
450 Fifth Street, NW., Washington, DC 20549, facts bearing upon whether
the application has been made in accordance with the rules of the Amex
and what terms, if any, should be imposed by the Commission for the
protection of investors. The Commission, based on the information
submitted to it, will issue an order granting the application after the
date mentioned above, unless the Commission determines to order a
hearing on the matter.
For the Commission, by the Division of Market Regulation,
pursuant to delegated authority.
Jonathan G. Katz,
Secretary.
[FR Doc. 95-2652 Filed 2-2-95; 8:45 am]
BILLING CODE 8010-01-M
